drugset / Trial / NCT03202992
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Non-randomizedSequentialOpen-labelTreatment
Summary
This study evaluates the use of ABI-1968, a topical cream, in the treatment of anal precancerous lesions in adults with and without human immunodeficiency virus (HIV) infection.
Timeline
- Start
- 2017-08-11
- Primary completion
- 2019-02-04
- Completion
- 2019-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABI-1968 | Unknown | — | Topical |